RS51707B - Kombinacija leka sastavljena od r, r - formoterola i ciklezonida - Google Patents

Kombinacija leka sastavljena od r, r - formoterola i ciklezonida

Info

Publication number
RS51707B
RS51707B YU20050429A YUP42905A RS51707B RS 51707 B RS51707 B RS 51707B YU 20050429 A YU20050429 A YU 20050429A YU P42905 A YUP42905 A YU P42905A RS 51707 B RS51707 B RS 51707B
Authority
RS
Serbia
Prior art keywords
combination medicament
combination
salt
medicament
ciclesonide
Prior art date
Application number
YU20050429A
Other languages
English (en)
Inventor
Christian Dr. Weimar
Klaus Dr. Dietzel
Degenhard Dr. Marx
Helgert dr. MÜLLER
Original Assignee
Nycomed Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh. filed Critical Nycomed Gmbh.
Publication of RS20050429A publication Critical patent/RS20050429A/sr
Publication of RS51707B publication Critical patent/RS51707B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glass Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)

Abstract

Lek za lečenje obolenja disajnih puteva, koji sadrži aktivno jedinjenje ciklezonida i R,R-formoterola u vezanoj kombinaciji zajedno sa uobičajenim ekscipijentima ili nosačima u primenjenom obliku pogodnom za inhalativnu primenu posredstvom praškastog inhalatora i gde je aktivno jedinjenje R,R- formoterola u obliku soli sa kiselinom i gde je kiselina fumarna kiselina ili tartarna kiselina.Prijava sadrži još 1 nezavisni i 8 zavisnih patentnih zahteva.
YU20050429A 2002-12-12 2003-12-11 Kombinacija leka sastavljena od r, r - formoterola i ciklezonida RS51707B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027797 2002-12-12
DE10306213 2003-02-13
PCT/EP2003/014045 WO2004052374A1 (en) 2002-12-12 2003-12-11 Combination medicament

Publications (2)

Publication Number Publication Date
RS20050429A RS20050429A (en) 2007-12-31
RS51707B true RS51707B (sr) 2011-10-31

Family

ID=32509778

Family Applications (1)

Application Number Title Priority Date Filing Date
YU20050429A RS51707B (sr) 2002-12-12 2003-12-11 Kombinacija leka sastavljena od r, r - formoterola i ciklezonida

Country Status (15)

Country Link
US (2) US7879833B2 (sr)
EP (1) EP1572217B1 (sr)
JP (1) JP4755495B2 (sr)
AT (1) ATE405275T1 (sr)
AU (1) AU2003293833B2 (sr)
CA (1) CA2508692C (sr)
DE (1) DE60323138D1 (sr)
DK (1) DK1572217T3 (sr)
ES (1) ES2312844T3 (sr)
HR (1) HRP20050611B1 (sr)
IS (1) IS2597B (sr)
PL (1) PL375819A1 (sr)
PT (1) PT1572217E (sr)
RS (1) RS51707B (sr)
WO (1) WO2004052374A1 (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8025896B2 (en) 2001-07-16 2011-09-27 Depuy Products, Inc. Porous extracellular matrix scaffold and method
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
EP1635845A1 (en) 2003-06-13 2006-03-22 ALTANA Pharma AG Formoterol and ciclesonide combination
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
US20080027034A1 (en) * 2004-09-10 2008-01-31 Shah Tushar P Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof
WO2011093814A2 (en) * 2010-01-29 2011-08-04 Mahmut Bilgic A pharmaceutical combination comprising formoterol and ciclesonide
CN107998109A (zh) * 2010-10-12 2018-05-08 西普拉有限公司 药物组合物

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE9716T1 (de) 1980-02-27 1984-10-15 Tate & Lyle Public Limited Company Kristalline glukose und verfahren zu deren herstellung.
US4816445A (en) 1984-06-21 1989-03-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Crystalline alpha-maltose
JP2518646B2 (ja) 1987-05-29 1996-07-24 株式会社 林原生物化学研究所 マルト−ス粉末の製造方法
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DE69012458T3 (de) 1989-05-31 2000-01-20 Fisons Plc, Ipswich Medikament und Inhalationsvorrichtung dafür.
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
ATE92762T1 (de) 1989-09-08 1993-08-15 Glaxo Group Ltd Medikamente.
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
US5178866A (en) 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
WO1992001730A1 (en) * 1990-07-26 1992-02-06 Monsanto Company Novel polyamines and method for preparation thereof
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
US5434304A (en) 1990-09-26 1995-07-18 Aktiebolaget Astra Process for preparing formoterol and related compounds
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US5795564A (en) 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US6866839B2 (en) 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
ATE246497T1 (de) 1991-06-10 2003-08-15 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
IT1250691B (it) 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
CZ288032B6 (cs) 1991-12-18 2001-04-11 Aktiebolaget Astra Farmaceutický prostředek pro podání inhalací
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
WO1994022899A1 (de) 1993-04-02 1994-10-13 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue prednisolonderivate
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of drug patramulations
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
US5811388A (en) 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
EP0833622B8 (en) 1995-06-12 2005-10-12 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
EP0852498A1 (en) 1995-09-26 1998-07-15 Takeda Chemical Industries, Ltd. Phosphorylamides, their preparation and use
DE19635498A1 (de) 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
US6599927B2 (en) 1996-10-11 2003-07-29 Astrazeneca Ab Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome
SE9603725D0 (sv) 1996-10-11 1996-10-11 Astra Ab New teatment
FR2754712B1 (fr) 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
ES2178015T3 (es) 1996-11-11 2002-12-16 Sepracor Inc Procedimiento de preparacion de isomeros de formoterol opticamente puros.
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US6613795B2 (en) 1996-11-11 2003-09-02 Christian Noe Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB2329939A (en) 1997-06-26 1999-04-07 Glaxo Group Ltd Self-lubricating valve stem for aerosol containers
US6470894B2 (en) 1997-09-19 2002-10-29 Thione International, Inc. Glutathione, green tea, grape seed extract to neutralize tobacco free radicals
EP1021172B1 (en) 1997-10-08 2002-04-10 Sepracor, Inc. Dosage form for aerosol administration
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
AU1507199A (en) 1997-12-15 1999-07-05 Yamanouchi Pharmaceutical Co., Ltd. Novel pyrimidine-5-carboxamide derivatives
SE9801368D0 (sv) 1998-04-20 1998-04-20 Astra Ab New use
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6241969B1 (en) 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
NZ509328A (en) 1998-07-24 2002-11-26 Jago Res A Medicinal aerosol formulations
ATE234604T1 (de) * 1998-08-04 2003-04-15 Jago Res Ag Medizinische aerosolformulierungen
EA005377B1 (ru) 1998-09-23 2005-02-24 Алтана Фарма Аг ТЕТРАГИДРОИМИДАЗО [1,2-h][1,7] НАФТИРИДИНОВЫЕ СОЕДИНЕНИЯ
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
US6352152B1 (en) 1998-12-18 2002-03-05 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6124268A (en) 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
JP2001048807A (ja) 1999-08-04 2001-02-20 Wakamoto Pharmaceut Co Ltd 難溶性薬物を水に溶解してなる製剤
DE19947234A1 (de) 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
GB0002336D0 (en) 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
GB0009607D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0015043D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
FI20002177A0 (fi) 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020183292A1 (en) 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
AU2002227123A1 (en) 2000-11-07 2002-05-21 Merck And Co., Inc. Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist
AU2002222304B2 (en) 2000-12-22 2004-03-18 Glaxo Group Limited Metered dose inhaler for salmeterol xinafoate
WO2002062317A2 (en) * 2001-02-06 2002-08-15 Innovata Biomed Limited Bimodal dry powder formulation for inhalation
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
WO2003006310A1 (fr) 2001-07-13 2003-01-23 Tfe Techniques Et Fabrications Electroniques Dispositif destine a indiquer acoustiquement a un plongeur equipe d'un scaphandre la pression de gaz de respiration dans le reservoir et/ou la pression hydrostatique
WO2003035030A1 (en) 2001-10-24 2003-05-01 Pari Gmbh Kit for the preparation of a pharmaceutical composition
KR20050044503A (ko) 2001-11-17 2005-05-12 아벤티스 파마 리미티드 흡착제 및 이의 용도
US20050020637A1 (en) 2001-11-19 2005-01-27 Wolfgang-Alexander Simon Agents for the treatment of airway disorders
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
ITMI20020808A1 (it) 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
RS57455B1 (sr) 2002-07-02 2018-09-28 Astrazeneca Ab Sterilna vodena suspenzija koja sadrži ciklezonid
WO2004019955A1 (en) 2002-08-30 2004-03-11 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
JP2006528228A (ja) 2003-05-22 2006-12-14 アルタナ　ファルマ　アクチエンゲゼルシャフト サルメテロール及びシクレソニドの組合せ物
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
EP1635845A1 (en) 2003-06-13 2006-03-22 ALTANA Pharma AG Formoterol and ciclesonide combination
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases

Also Published As

Publication number Publication date
HRP20050611A2 (en) 2006-09-30
AU2003293833A1 (en) 2004-06-30
WO2004052374A1 (en) 2004-06-24
IS2597B (is) 2010-03-15
US20060025392A1 (en) 2006-02-02
US20110086827A1 (en) 2011-04-14
ES2312844T3 (es) 2009-03-01
EP1572217A1 (en) 2005-09-14
JP2006514686A (ja) 2006-05-11
AU2003293833B2 (en) 2009-10-01
RS20050429A (en) 2007-12-31
DK1572217T3 (da) 2008-12-15
PT1572217E (pt) 2008-11-28
US7879833B2 (en) 2011-02-01
PL375819A1 (en) 2005-12-12
JP4755495B2 (ja) 2011-08-24
DE60323138D1 (de) 2008-10-02
US8258124B2 (en) 2012-09-04
HRP20050611B1 (hr) 2013-12-20
CA2508692C (en) 2012-04-03
ATE405275T1 (de) 2008-09-15
IS7910A (is) 2005-06-23
CA2508692A1 (en) 2004-06-24
EP1572217B1 (en) 2008-08-20

Similar Documents

Publication Publication Date Title
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
HRP20050611A2 (en) Combination medicament
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
HK1076095A1 (en) Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
HK1064669A1 (en) Substituted 1-oxy-2,8-diaza-spiro Ä4,5Üdec-2-ene derivatives as medicaments for the treatment of pain.
IL164442A0 (en) Benzoxazinone-derived compounds, their preparationand use as medicaments
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
TW200744612A (en) New combination
PT1638943E (pt) Novos derivados de imidazoles, sua preparação e sua utilização como medicamento
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
HK1095584A1 (en) Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
AU2002335304A1 (en) The use of berberine as insulin sensitizer
WO2005082873A3 (de) 1,4-benzothiazepane und derivate
MXPA05009243A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados.
TW200510461A (en) Disialoundecaglycosylasparagine - fatty acid amide and medicine containing the same
RU2002117643A (ru) Люплатекс, обладающий противолучевыми свойствами
HK1073656A1 (en) Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
UA97237C2 (ru) Производные таксола с противоопухолевой активностью
AU2003232698A1 (en) Use of a n,n'-dibenzyl-thiourea as medicine
SI1509498T1 (sl) Pentafluorosulfanil-benzoilgvanidini, postopek za njihovo pripravo, njihova uporaba kot zdravilo ali diagnosticno sredstvo in zdravilo, ki jih vsebuje
AU2003255063A1 (en) The medical use of 11,11`-dideoxyverticillin a
SI1532124T1 (sl) Uporaba nitrilnih derivatov kot zdravila